title: Continuous infusion of mitoxantrone combined with high-dose cytarabine in refractory/relapsed acute myeloblastic leukemia and blast crisis of chronic myelogenous leukemia.
authors.affiliation: II. Department of Internal Medicine, University of Vienna, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Linkesch
authors.forename: J
authors.initials: J
authors.lastname: Thaler
authors.forename: C
authors.initials: C
authors.lastname: Gattringer
authors.forename: G
authors.initials: G
authors.lastname: Konwalinka
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000188:drug therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001317:Austria; D001752:Blast Crisis / Q000188:drug therapy*; D003561:Cytarabine / Q000008:administration & dosage; D004341:Drug Evaluation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone